11.5 C
New York
Wednesday, February 8, 2023

What Are The Chances Of Organon & Co. (NYSE: OGN) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Organon & Co. (OGN) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $28.84. The Organon & Co. has recorded 28,004 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Stocks Info

As a NYSE listed company, OGN falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. At the end of the last regular session, the stock closed at $28.84 and fluctuated between $28.84 as its day high and $27.93 as its day low. The current market capitalization of Organon & Co. is $7.40B. A total of 1.87 million shares were traded on the day, compared to an average of 2.01M shares.

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, OGN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 35 BUYs and 35 SELLs from insiders. Insiders purchased 170,248 shares during that period but sold 69,146.

Dividend

Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Organon & Co. pays an annual dividend of $1.12, resulting in a dividend yield of 3.88%, and it has a price to earnings (P/E) ratio of 7.28. OGN’s most recent ex-dividend date was 11/10/2022 when it declared a $0.28 quarterly dividend that was paid in cash on 12/15/2022. Previously, the company paid the dividend on 9/15/2022 with an ex-dividend date of 8/12/2022. The OGN stock dividend was $0.28 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for OGN in the last 3 months, the mean price target is $33.13 with high estimates of $43.00 and low estimates of $22.00. In terms of 52-week highs and lows, OGN has a high of $39.47 and a low of $22.88.

As of this writing, OGN has an earnings estimate of $1.1 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $1.39 per share and a lower estimate of $0.92. The company reported an EPS of $1.65 in the last quarter, which was 26.90% higher than expectations of $1.3.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 9 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OGN is Overweight with a score of 3.71. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 4 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles